Product Information
ALVESCO 160 MCG INHALER is a brand product labeled by Covis Pharma US, Inc, priced at $42.9735 per GM under NDC 70515071201. Its NADAC has been published 398 times since Jan 9, 2019.
FDA first approved this application on Jan 10, 2008.
Strength
160 ug/1
Manufacturer
Covis Pharma US, IncNDC
70515071201
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
CICLESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA021658FDA Approved
1/10/2008
On Market Since
3/26/2018
Price Statistics
The NADAC for ALVESCO 160 MCG INHALER has been published 398 times since Jan 9, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.9735 per GM |
|---|---|
| All-time high | $43.5144 (Feb 12, 2020) |
| All-time low | $42.9471 (Dec 23, 2020) |
| 52-week high | $43.0458 |
| 52-week low | $42.9735 |
| Median price | $43.1017 |
| Average price | $43.1205 |
| Largest weekly change | -1.3% (Feb 19, 2020) |
| Weeks tracked | 398 |
| Tracking since | Jan 9, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ciclesonide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALVESCO 160 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for ALVESCO 160 MCG INHALER, manufactured by Covis Pharma US, Inc, is $42.9735 per GM (NDC 70515071201), effective Aug 19, 2026.
How has the price of ALVESCO 160 MCG INHALER changed over time?
Over the history we have for it, the NADAC for ALVESCO 160 MCG INHALER has held within roughly two percent of its current level. It has been tracked across 398 weekly CMS publications since Jan 9, 2019.
What are the highest and lowest recorded NADAC prices for ALVESCO 160 MCG INHALER?
Since Jan 9, 2019, the NADAC for ALVESCO 160 MCG INHALER has ranged from a low of $42.9471 (Dec 23, 2020) to a high of $43.5144 (Feb 12, 2020), with a median of $43.1017 per GM.
Are there cheaper alternatives to ALVESCO 160 MCG INHALER?
No other NADAC-published product currently shares the active ingredient and strength of ALVESCO 160 MCG INHALER in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALVESCO 160 MCG INHALER?
ALVESCO 160 MCG INHALER (NDC 70515071201) is labeled by Covis Pharma US, Inc, and CMS classifies it as a brand product.